Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors
Geoffroy Venton(Inserm), Régis Costello(Inserm), C. L. Brunet(Hôpital de la Conception), Pierre Suchon(Inserm), Yasmine Labiad(Inserm), F. Sanderson(Hôpital de la Conception), Mileidys Pérez‐Alea(Vall d'Hebron Institut de Recerca), Céline Baier(Inserm), Laure Farnault(Aix-Marseille Université), G. Martin, Pascale Poullin(Centre National de la Recherche Scientifique), G Quash, Guy Fournet(Lyon 1 Université), Cong Tu Nguyen(Inserm), İsmail Çeylan
Cited by 74
Related Papers
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
|Journal of the American Heart Association|2020|298
Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism
|The American Journal of Human Genetics|2015|274
Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
|Blood|2019|238
Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels
|Circulation|2019|170
Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes
|Circulation Genomic and Precision Medicine|2020|170